EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Characteristics and Prognostic Analysis of EBV-Positive HIV-Associated Diffuse Large B-Cell Lymphoma in China: A Retrospective Single-Center Study

Lizhi Feng iD, Haolan He, Han Zhao, Bo Liu, Zhimin Chen, Xinhua Liu, Haisheng Yu iD, Fengyu Hu, Xiaoping Tang, Linghua Li iD

Current Oncology · 05.08.2026 · 33 (8) · 466

DOI: 10.3390/curroncol33080466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 05.08.2026. Verfasst von Lizhi Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections, Herpesvirus 4, Human, HIV Infections. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, Joint Funding Project of the Guangzhou Municipal Science and Technology Bureau and Guangzhou Medical University/Guangzhou Eighth People's Hospital, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV) contributes to human immunodeficiency virus (HIV)-associated diffuse large B-cell lymphoma (DLBCL) pathogenesis. We retrospectively analyzed clinical features and outcomes of EBV-positive (n = 32) and -negative (n = 71) cases. EBV status was determined using in situ hybridization. Immunological parameters, histological subtype, systemic B symptoms, plasma EBV DNA, and response to therapy were examined. Survival was compared using Kaplan–Meier analysis. Factors associated with overall survival (OS) and progression-free survival (PFS) in EBV-positive patients were examined using Cox regression models. EBV-positive cases showed a higher proportion of non-germinal center B cell subtypes and B symptoms, higher circulating EBV viral loads, and lower CD4+ T-cell counts at diagnosis than EBV-negative cases. OS did not differ significantly within the full cohort but was shorter in EBV-positive cases with high International Prognostic Index scores or CD4+ T-cell counts ≥ 50 cells/μL. Concurrent infections and elevated plasma EBV DNA levels remained associated with unfavorable survival outcomes. EBV-positivity in HIV-associated DLBCL is related to more aggressive clinical and immunological features and independently predicts poorer survival outcomes in high-risk subgroups. Plasma EBV DNA may reliably indicate EBV status and serve as a prognostic biomarker. Integrating these features into clinical decision-making may enhance risk stratification and inform individualized treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHIV InfectionsHumansRetrospective StudiesPrognosisFemaleChinaMaleMiddle AgedAdult

Stichwörter der Autor:innen

Epstein–Barr virushuman immunodeficiency virus-associated diffuse large B-cell lymphomainfectionprognosisrisk stratification

Autor:innen und Institutionen

  • Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Guangzhou Medical Research Institute of Infectious Diseases, Guangzhou 510440, China.
  • Institute of Infectious Disease, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Guangzhou Key Laboratory of Clinical Pathogen Research for Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.

ORCID-Profile: Lizhi Feng, Haisheng Yu, Linghua Li

Förderung

  • Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
  • Joint Funding Project of the Guangzhou Municipal Science and Technology Bureau and Guangzhou Medical University/Guangzhou Eighth People's Hospital
  • National Key Research and Development Program of China
  • Guangzhou Medical University

Zitieren

APA

Feng, L., He, H., Zhao, H., Liu, B., Chen, Z., Liu, X., Yu, H., Hu, F., Tang, X., & Li, L. (2026). Clinical Characteristics and Prognostic Analysis of EBV-Positive HIV-Associated Diffuse Large B-Cell Lymphoma in China: A Retrospective Single-Center Study. Current Oncology, 33(8), 466. https://doi.org/10.3390/curroncol33080466

Vancouver

Feng L, He H, Zhao H, Liu B, Chen Z, Liu X, et al. Clinical Characteristics and Prognostic Analysis of EBV-Positive HIV-Associated Diffuse Large B-Cell Lymphoma in China: A Retrospective Single-Center Study. Current Oncology. 2026;33(8):466. doi:10.3390/curroncol33080466

BibTeX
@article{Feng2026,
  author = {Feng, Lizhi and He, Haolan and Zhao, Han and Liu, Bo and Chen, Zhimin and Liu, Xinhua and Yu, Haisheng and Hu, Fengyu and Tang, Xiaoping and Li, Linghua},
  title = {Clinical Characteristics and Prognostic Analysis of EBV-Positive HIV-Associated Diffuse Large B-Cell Lymphoma in China: A Retrospective Single-Center Study},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {8},
  pages = {466},
  doi = {10.3390/curroncol33080466}
}
Kostenlos starten →